| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |